/ Who we serve
Who we serve

Who we serve

From AI protein design to rare-disease medicine: four groups, one cell-free process — research material today, clinical material on the same process tomorrow.

Open now

Academic labs

Express more of your designs. Cell-free synthesis turns a DNA sequence into purified protein without cloning, transformation or culture — a design round becomes one batch, not weeks at the bench.

Services Research material, Protein complex production

Validation open now

Rare disease therapeutic developers

Clinical-grade production at the volumes rare diseases need. One process from your first research batch to clinical material — no process transfer, no re-validation cliff.

Services Research material, Clinical material

In development · patent filing

Orphan drug biosimilar sponsors

We are developing a universal scarless extraction method for protein drugs and filing against it. We want to talk to sponsors — and co-sponsor drugs.

Services Research material, Clinical material

Send a sequence this week

Whatever team you are, research material ships within a week. Paste your protein sequence and send the message — we get back to you within 24 hours.